Vancomycin’s potency against Mycobacterium tuberculosis in the hollow fiber system model
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vancomycin’s potency against Mycobacterium tuberculosis in the hollow fiber system model
Authors
Keywords
Peptidoglycan synthesis inhibitor, β-Lactam, Tuberculosis, Synergy, Antagonism
Journal
Journal of Global Antimicrobial Resistance
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-01-26
DOI
10.1016/j.jgar.2021.01.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Once-a-week tigecycline for the treatment of drug-resistant TB
- (2019) Devyani Deshpande et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Drug Penetration Gradients Associated with Acquired Drug Resistance in Tuberculosis Patients
- (2018) Keertan Dheda et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT): A Prospective, Open-Label, Randomized Study
- (2018) David E Griffith et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Minocycline Immunomodulates via Sonic Hedgehog Signaling and Apoptosis and Has Direct Potency Against Drug-Resistant Tuberculosis
- (2018) Devyani Deshpande et al. JOURNAL OF INFECTIOUS DISEASES
- World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
- (2017) Dennis Falzon et al. EUROPEAN RESPIRATORY JOURNAL
- D-cycloserine increases the effectiveness of vancomycin against vancomycin-highly resistant Staphylococcus aureus
- (2017) Fumiaki Tabuchi et al. JOURNAL OF ANTIBIOTICS
- The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
- (2017) Keertan Dheda et al. Lancet Respiratory Medicine
- Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis
- (2017) Devyani Deshpande et al. Science Advances
- Crystal structures of the transpeptidase domain of the Mycobacterium tuberculosis penicillin-binding protein PonA1 reveal potential mechanisms of antibiotic resistance
- (2016) Ekaterina V. Filippova et al. FEBS Journal
- Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance
- (2016) Christopher A Desjardins et al. NATURE GENETICS
- Increased Vancomycin Susceptibility in Mycobacteria: a New Approach To Identify Synergistic Activity against Multidrug-Resistant Mycobacteria
- (2015) Karine Soetaert et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments
- (2015) Jotam G. Pasipanodya et al. CLINICAL INFECTIOUS DISEASES
- Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes
- (2015) Tawanda Gumbo et al. CLINICAL INFECTIOUS DISEASES
- Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm
- (2015) Tawanda Gumbo et al. CLINICAL INFECTIOUS DISEASES
- Peptidoglycan synthesis inMycobacterium tuberculosisis organized into networks with varying drug susceptibility
- (2015) Karen J. Kieser et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- How sisters grow apart: mycobacterial growth and division
- (2014) Karen J. Kieser et al. NATURE REVIEWS MICROBIOLOGY
- Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia
- (2013) Natasha E. Holmes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Metabolomics Reveal d-Alanine:d-Alanine Ligase As the Target of d-Cycloserine in Mycobacterium tuberculosis
- (2013) Gareth A. Prosser et al. ACS Medicinal Chemistry Letters
- Inactivation of Mycobacterium tuberculosis l,d-Transpeptidase LdtMt1by Carbapenems and Cephalosporins
- (2012) Vincent Dubée et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Antibiotic Resistance Arrow of Time: Efflux Pump Induction Is a General First Step in the Evolution of Mycobacterial Drug Resistance
- (2012) Aurelia M. Schmalstieg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro and In Vivo Modeling of Tuberculosis Drugs and its Impact on Optimization of Doses and Regimens
- (2012) Shashikant Srivastava et al. CURRENT PHARMACEUTICAL DESIGN
- From the regulation of peptidoglycan synthesis to bacterial growth and morphology
- (2011) Athanasios Typas et al. NATURE REVIEWS MICROBIOLOGY
- Structure of theMycobacterium tuberculosisd-Alanine:d-Alanine Ligase, a Target of the Antituberculosis Drug d-Cycloserine
- (2010) John B. Bruning et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Mycobacterium tuberculosis protein LdtMt2 is a nonclassical transpeptidase required for virulence and resistance to amoxicillin
- (2010) Radhika Gupta et al. NATURE MEDICINE
- Interaction and Modulation of Two Antagonistic Cell Wall Enzymes of Mycobacteria
- (2010) Erik C. Hett et al. PLoS Pathogens
- Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs
- (2009) T. Gumbo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started